Mittelbiberach, Germany

Peter Seiger

This inventor holds 1 USPTO granted patent. Top assignee: Boehringer Ingelheim Pharma Gmbh & Co Kg. Active years: 2005.


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Peter Seiger

Introduction

Peter Seiger is a notable inventor based in Mittelbiberach, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of inhalation therapies. His work has been instrumental in advancing the treatment options available for respiratory conditions.

Latest Patents

Peter Seiger holds a patent for "Powder formulations containing tiotropium suitable for inhalation." This patent describes a method of making a physically stable and homogenous powdered pharmaceutical composition comprising a tiotropium salt and a physiologically acceptable excipient. This innovation is crucial for improving the delivery and effectiveness of inhaled medications.

Career Highlights

Seiger is currently employed at Boehringer Ingelheim Pharma GmbH & Co. KG, a leading global pharmaceutical company. His role involves research and development, focusing on innovative solutions for respiratory therapies. His expertise in pharmaceutical formulations has contributed to the company's reputation for excellence in the industry.

Collaborations

Throughout his career, Peter has collaborated with several talented individuals, including Andreas Mathes and Peter Specht. These collaborations have fostered a creative environment that encourages the development of groundbreaking pharmaceutical solutions.

Conclusion

Peter Seiger's contributions to the field of inhalation therapies exemplify the impact of innovation in pharmaceuticals. His work continues to influence the development of effective treatments for respiratory conditions, showcasing the importance of research and collaboration in advancing healthcare.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…